Trinity Biotech (TRIB) Non Operating Income (2009 - 2024)

Trinity Biotech (TRIB) has reported Non Operating Income for 12 consecutive years, with -$4.3 million the latest figure, recorded in Q4 2024.

• Quarterly Non Operating Income fell 148.2% year-over-year to -$4.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$9.6 million (up 3.21% YoY) and the FY2025 annual result came in at -$21.4 million, down 123.61% from the prior year.
• Non Operating Income slipped to -$4.3 million in Q4 2024 per TRIB's latest filing, from -$2.2 million in the prior quarter.
• Over the last five years, Non Operating Income for TRIB reached as high as -$209000.0 in Q1 2024 and fell as low as -$12.0 million in Q1 2022.
• A 4-year average of -$3.6 million and a median of -$2.3 million in 2023 frame the typical range for Non Operating Income.
• The largest YoY upside for Non Operating Income was 91.28% in 2024 against a maximum downside of 148.2% in 2024.
• Year by year, Non Operating Income stood at -$1.2 million in 2021, then slumped by 58.95% to -$1.9 million in 2022, then advanced by 6.95% to -$1.7 million in 2023, then slumped by 148.2% to -$4.3 million in 2024.
• According to Business Quant data, Non Operating Income over the past three periods registered -$4.3 million, -$2.2 million, and -$2.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.